Literature DB >> 8780717

Functional antagonistic properties of clozapine at the 5-HT3 receptor.

B Hermann1, C H Wetzel, E Pestel, W Zieglgänsberger, F Holsboer, R Rupprecht.   

Abstract

The atypical neuroleptic clozapine is thought to exert its psychopharmacological actions through a variety of neurotransmitter receptors. It binds preferentially to D4 and 5-HT2 receptors; however, little is known on it's interaction with the 5-HT3 receptor. Using a cell line stably expressing the 5-HT3 receptor, whole-cell voltage-clamp analysis revealed functional antagonistic properties of clozapine at low nanomolar concentrations in view of a binding affinity in the upper nanomolar range. Because the concentration of clozapine required for an interaction with the 5-HT3 receptor can be achieved with therapeutical doses, functional antagonistic properties at this ligand-gated ion channel may contribute to its unique psychopharmacological profile.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780717     DOI: 10.1006/bbrc.1996.1278

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Modulation of ligand-gated ion channels by antidepressants and antipsychotics.

Authors:  Gerhard Rammes; Rainer Rupprecht
Journal:  Mol Neurobiol       Date:  2007-04       Impact factor: 5.590

Review 2.  The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders.

Authors:  Erin M MacKenzie; John Odontiadis; Jean-Michel Le Mellédo; Trevor I Prior; Glen B I Baker
Journal:  Cell Mol Neurobiol       Date:  2007-08       Impact factor: 5.046

3.  Effects of Clozapine on the Gut: Cross-Sectional Study of Delayed Gastric Emptying and Small and Large Intestinal Dysmotility.

Authors:  Susanna Every-Palmer; Stephen J Inns; Eve Grant; Pete M Ellis
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

Review 4.  Antipsychotic-Induced Constipation: A Review of the Pathogenesis, Clinical Diagnosis, and Treatment.

Authors:  Yue Xu; Nousayhah Amdanee; Xiangrong Zhang
Journal:  CNS Drugs       Date:  2021-08-24       Impact factor: 5.749

Review 5.  Tapping into 5-HT3 Receptors to Modify Metabolic and Immune Responses.

Authors:  Helen Irving; Ilona Turek; Christine Kettle; Nor Yaakob
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

6.  Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptors.

Authors:  Gerhard Rammes; Christine Hosp; Brigitte Eisensamer; Sascha Tanasic; Caroline Nothdurfter; Walter Zieglgänsberger; Rainer Rupprecht
Journal:  PLoS One       Date:  2009-08-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.